Cheaper versions of the most expensive drugs may be coming, but monopolies will likely remain

Cheaper versions of the most expensive drugs may be coming, but monopolies will likely remain

In May, the Food and Drug Administration issued much-anticipated guidance that could revolutionize t...
read more